EPL Ltd Q4 FY2024 Concall Summary

Key Takeaways

• Double-digit EBITDA streak continues: EBITDA grew 16.5% YoY, the sixth straight quarter of double-digit growth, with margins expanding 164 bps to 18.5%.
• Revenue growth masked by price headwinds: Reported revenue grew 6.2%, but underlying volume addition is "materially ahead" of this number because negative pricing and mix are subduing the top line.
• Americas surges, Europe restructures: Americas revenue jumped 15.9% with Brazil now margin-accretive, while Europe took a ₹14 crore charge to optimize headcount and shift manufacturing lines to Poland.
• Sustainable tube strategy is a deliberate wallet-share play: Management is choosing faster conversion over premium pricing, betting that volume gains will be permanent even if near-term pricing power is sacrificed.
• What to watch next quarter: Whether negative pricing truly begins to unwind into neutral or positive territory, the pace of US margin improvement, and any early signs that the Europe restructuring benefits are accruing.

Top-Line: The Price-Mix Overhang

• Volume vs. reported growth: Simple (unsophisticated) volume addition is running materially ahead of reported revenue, because negative price-mix is compressing the top line. Management disclosed this gap exists but declined to share volume or raw-material consumption data, arguing it would "just create confusion."
• The unwind thesis: Negative pricing has begun to unwind and management expects it to slowly turn neutral or positive. As that happens, the positive trend in reported revenue growth will become visible.
• Category mix shift underway: Personal care and beyond grew 8.1% versus 5% in oral care and now represents 47% of total business, a structural shift toward faster-growing segments.
• EAP Q4 dip is seasonal, not structural: Q4 in EAP is always subdued due to Chinese New Year, and the prior-year quarter was boosted by a post-COVID reopening surge. Underlying China performance is solid, with a shift toward beauty and cosmetics and export opportunities.

Anand Kripalu: "by and large around the world, we are leading the conversion in terms of number of sustainable tubes being supplied, and some of those gains that are coming will be permanent."

Regional Profitability: Americas Inflecting, Europe Resetting

• Americas margin is not a one-off: The region's EBITDA margin reached 18%, with Brazil already margin-accretive to the Americas total. A detailed program to improve US margins is in place and expected to show significant improvement during this year.
• Brazil delivering ahead of schedule: The Greenfield plant has fulfilled 100% of its anchor customer's demand and has already received orders from other MNC and local customers. Management sees the opportunity as "more and more" with each passing month and expects Brazil to be significantly accretive to growth.
• Europe restructuring is a three-part fix: A ₹14 crore exceptional charge covers (1) headcount optimization at management and operator levels, (2) manufacturing line moves from a higher-cost German site to Poland, and (3) a new Poland center of excellence for printing laminates plus a shared services center for finance and planning. Benefits are expected to start accruing this year itself, with a mid-teens margin target in the "foreseeable future."
• Europe EBIT- EBITDA gap explained: Higher depreciation from two large capitalizations at the Poland plant at the start of FY24, which were absent in the prior-year quarter, widened the gap between EBITDA and EBIT.

Anand Kripalu: "with every passing month, the opportunities seem more and more I think rather than the other way around."

Sustainable Tubes: Strategy Over Margin

• Sales contribution doubled: Sustainable tube sales more than doubled to 21% of the total, driven by a deliberate strategy to lead conversion globally rather than charge a premium.
• The pricing trade-off: Management acknowledges sustainable tubes could command better pricing by default (first-mover advantage), but the strategic choice is to accelerate conversion and gain wallet share. Charging a premium, they argue, would slow adoption or cede share to competitors willing to supply at lower prices.
• Margins are at least comparable: Sustainable tube margins are greater than or equal to margins on regular tubes, so the volume-share strategy does not dilute unit economics even if it forgoes potential upside.
• Neoseam traction building: The Neoseam tube technology has entered the market and is steadily gaining traction across regions, supporting the broader push into beauty and cosmetics.

Anand Kripalu: "If you try and charge a premium, chances are that you will slow down the process of conversion or you will lose wallet share in the conversion because somebody else will give it at a lower price. However, if you give it where you do not present an obstacle to conversion, then the chances are, you will convert faster and gain wallet share during that conversion, and that has been our strategy."

Capital Allocation & Balance Sheet

• CAPEX normalizing: Excluding M&A or a new Greenfield, annual CAPEX will be in line with amortization. Over any two-year block, total CAPEX will match total amortization, again excluding M&A and Greenfield.
• Internal accruals sufficient: Cash generation from operations will fully fund the CAPEX needed to support the double-digit growth target.
• Interest cost steady-state: The step-up in interest cost reflects the Brazil Greenfield plant's commercialization in Q1 FY24, which moved interest from capitalization to the P&L. Quarterly interest will remain at roughly ₹32 crore, barring M&A or another Greenfield.
• Dividend increased: A proposed final dividend of ₹2.30 per share marks an increase.
• Exceptional items: Beyond the Europe restructuring (₹14 crore), the quarter included a ₹46.5 crore charge from Egypt's currency devaluation following the Egyptian pound's free float and 60% depreciation.

Beauty & Cosmetics: The Next Growth Vector

• Headcount and technology investment: EPL is actively adding headcount to pursue smaller beauty and cosmetics customers, supported by the Neoseam technology platform. Management expects these resources to "start playing out in the next few quarters."
• Pharma is a slow-burn opportunity: Once a conversation starts with a pharma customer, conversion takes at least a year, if not longer, so near-term revenue contribution will be limited.
• India business solid, not losing share: The standalone India business is performing well, with orders received from large customers that will boost growth. Volume growth remains solid even if reported numbers are muted by price-mix.

Guidance & Commitments

Key Metrics